U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market to Surpass US$ 1,562.63 Mn by 2030 CAGR of 7.4% | Chart industries, OxyGo HQ Florida, LLC, Koninklijke Philips N.V., ResMed Inc.

A device called a portable oxygen concentrator stabilises the amount of oxygen in a patient’s blood while providing oxygen therapy at significantly higher concentrations than ambient air. They are trained to give oxygen to people who have respiratory conditions such chronic obstructive pulmonary disease. Patients receive 95% pure oxygen using a mask after the concentrator separates nitrogen and oxygen from ambient air, discarding the nitrogen.

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5370

Impact

The financial standing of companies in all industries, including the private healthcare sector, has been harmed by the COVID-19 outbreak and lockdown in numerous nations throughout the world. The COVID-19 pandemic has had an influence on the whole healthcare supply chain, mostly as a result of the extreme lockdown in some areas.

The COVID-19 epidemic has had three main effects on the economies of different parts of the world: a direct influence on supply and demand; disruptions in the distribution system; and a financial impact on businesses and financial markets. Transporting and distributing medical supplies is a difficulty in a number of nations, including Thailand, Singapore and Indonesia.

Medical oxygen concentrators are in greater demand as a result of the COVID-19 pandemic. In essence, COVID-19 is a respiratory condition that affects the lungs and, in severe situations, lowers the oxygen level. The key characteristic of COVID-19 is bilateral pneumonia, which increased the need for supplementary oxygen during that time. When liquid oxygen is scarce, oxygen concentrators are utilised for oxygen therapy instead of oxygen tanks because the latter can run continuously.

The market for portable medical oxygen concentrators in the United States and Asia Pacific is anticipated to reach US$ 884.58 million in 2022 and grow at a 7.4% CAGR during the forecast period (2022-2030).

Drivers

Growing numbers of respiratory illnesses are anticipated to fuel expansion. For instance, data from AME Publishing Company, a globally significant open access publisher, published in April 2021, showed that in Japan in 2020, the total prevalence of COPD in the general population aged 40 years was roughly 10%.

The expansion of the U.S. and Asia Pacific portable oxygen concentrator markets is anticipated to be fueled by key market players’ emphasis on organic growth tactics including new launches. For instance, OMRON Healthcare, a leader in home blood pressure monitoring and solutions for the management of cardiovascular disease, announced the debut of a portable oxygen concentrator in July 2022 as its most recent development in the oxygen therapy category. It is a medical oxygen concentrator that uses molecular sieve technology to deliver high purity oxygen continuously at a rate of 5 litres per minute with an output concentration of more than 90%. The item is made to help homecare providers manage the therapeutic and daily living requirements of almost all patients with COPD and respiratory issues.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5370

Market Restraint

Product recalls for portable medical oxygen systems are predicted to restrain the growth of the portable oxygen concentrator market in the United States and Asia Pacific. Therefore, an increase in recalls may have an impact on manufacturers’ and supply networks’ production capacities. For instance, the CAIRE FreeStyle Comfort Portable Oxygen Concentrator with autoSAT, UltraSense, and autoDOSE model was recalled on March 25, 2022, according to the U.S. FDA. Device was not approved for distribution in the United States, according to the manufacturer, therefore the recall. On March 25, 2022, the company conducting the recall first contacted the customers through voicemail and email. The email advised the consignee that the FDA permission prevented the two impacted units from being sold in the United States or any of its territories.

Regional Analysis

For instance, the National Heart, Lung, and Blood Institute estimates that around 15 million persons in the United States suffer from chronic obstructive pulmonary disease by the year 2022. In addition, the chronic lower respiratory disease is the fourth greatest cause of death in the United States, according to the Centers for Disease Control and Prevention.

Competitive Landscape

Koninklijke Philips N.V., Chart Industries, Drive DeVilbiss Healthcare llc, OxyGo HQ Florida, LLC, NAREENA LIFESCIENCES PRIVATE LIMITED, ResMed Inc., CONTEC MEDICAL SYSTEMS CO.,LTD., Precision Medical, Inc., BPL Medical Technologies, O2 CONCEPTS, LLC, CAIRE INC., GCE Group, Besco Medical Limited, and Nidek Medical Product are major market.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: U.S. & Asia Pacific Portable Medical Oxygen Concentrators Industry Impact

Chapter 2 Global U.S. & Asia Pacific Portable Medical Oxygen Concentrators Competition by Types, Applications, and Top Regions and Countries
2.1 Global U.S. & Asia Pacific Portable Medical Oxygen Concentrators (Volume and Value) by Type
2.3 Global U.S. & Asia Pacific Portable Medical Oxygen Concentrators (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Company Profiles and Key Figures in U.S. & Asia Pacific Portable Medical Oxygen Concentrators Business
Chapter 5 Global U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market Forecast (2022-2028)
Chapter 6 Conclusions
Research Methodology